EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Precision‐Engineered PROTACs: Integrating Physical and Chemical Strategies for Targeted Cancer Therapy

Hong Yao, Yujing Zhang, Haibo Zhao, Meng Liu, Chang Liu, Pengyun Wang, Wujun Chen, Zhu Guo, Dongming Xing, Jinghua Yang, Bing Li, Chao Wang iD

Small · 2026

DOI: 10.1002/smll.202512640 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, 2026. Verfasst von Hong Yao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Neoplasms, Molecular Targeted Therapy, Precision Medicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Youth Innovation Team Development Program of Shandong Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis‐targeting chimeras (PROTACs) have emerged as a transformative therapeutic strategy for targeted protein degradation, offering substantial potential for treating various diseases by specifically eliminating pathogenic proteins. However, the clinical translation of PROTAC technology faces significant challenges due to limited target selectivity, which may lead to off‐target effects and potential toxicity in healthy tissues. Recent advances have focused on developing conditionally activatable PROTAC systems to improve their specificity and safety profile. This review comprehensively examines two primary classes of engineered PROTACs: (i) physically regulated systems, including photo‐activatable, radiation, and ultrasound‐activatable platforms, and (ii) chemically controlled approaches employing bioorthogonal conjugation strategies. We systematically analyze their molecular mechanisms, current clinical applications in oncology, and existing limitations regarding therapeutic efficacy and safety. The development of these precisely controlled PROTAC platforms promises to significantly enhance the clinical utility of targeted protein degradation technology in modern drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMolecular Targeted TherapyPrecision MedicineHumansProteolysis Targeting ChimeraProteolysisAnimals

Stichwörter der Autor:innen

PROTACschemical controlphysical stimuli‐activatableprecision therapeuticstargeted degradation

Substanzen

Proteolysis Targeting Chimera

Autor:innen und Institutionen

  • Department of Pharmacy, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Shandong, China.
  • Qingdao Medical College, Qingdao University, Qingdao, Shandong, China.
  • Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
  • Department of Orthopedics, Zibo Central Hospital, Zibo, Shandong, China.
  • Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, Shandong, China.
  • School of Life Sciences, Tsinghua University, Beijing, China.

ORCID-Profile: Chao Wang

Förderung

  • National Natural Science Foundation of China
  • Youth Innovation Team Development Program of Shandong Province
  • China Postdoctoral Science Foundation
  • Postdoctoral Innovation Program of Shandong Province
  • Shandong Taishan Scholars Young Experts Program
  • Natural Science Foundation Project of Shandong Province
  • Qingdao Natural Science Foundation Key Project
  • Qingdao Postdoctoral Science Foundation

Zitieren

APA

Yao, H., Zhang, Y., Zhao, H., Liu, M., Liu, C., Wang, P., Chen, W., Guo, Z., Xing, D., Yang, J., Li, B., & Wang, C. (2026). Precision‐Engineered PROTACs: Integrating Physical and Chemical Strategies for Targeted Cancer Therapy. Small. https://doi.org/10.1002/smll.202512640

Vancouver

Yao H, Zhang Y, Zhao H, Liu M, Liu C, Wang P, et al. Precision‐Engineered PROTACs: Integrating Physical and Chemical Strategies for Targeted Cancer Therapy. Small. 2026. doi:10.1002/smll.202512640

BibTeX
@article{Yao2026,
  author = {Yao, Hong and Zhang, Yujing and Zhao, Haibo and Liu, Meng and Liu, Chang and Wang, Pengyun and Chen, Wujun and Guo, Zhu and Xing, Dongming and Yang, Jinghua and Li, Bing and Wang, Chao},
  title = {Precision‐Engineered PROTACs: Integrating Physical and Chemical Strategies for Targeted Cancer Therapy},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.202512640}
}
Kostenlos starten →